Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging SARS-CoV-2 variants: Why, how, and what's next? | Cell Insight | 2022 | 37193049 | PubTator, text mining | PubMed |
| Screening of SARS-CoV-2 antivirals through a cell-based RNA-dependent RNA polymerase (RdRp) reporter assay. | Cell Insight | 2022 | 37192863 | PubTator, text mining | PubMed |
| Analysis of the potential association between ferroptosis and immune in hepatocellular carcinoma and their relationship with prognosis. | Front Oncol | 2022 | 36776357 | PubTator, text mining | PubMed |
| A reverse genetics system for human rotavirus G2P[4]. | J Gen Virol | 2022 | 36748482 | PubTator, text mining | PubMed |
| Biology of the SARS-CoV-2 Coronavirus. | Biochemistry (Mosc) | 2022 | 36717455 | PubTator, text mining | PubMed |
| Subtyping of major SARS-CoV-2 variants reveals different transmission dynamics based on 10 million genomes. | PNAS Nexus | 2022 | 36714842 | PubTator, text mining | PubMed |
| Protein post-translational modification in SARS-CoV-2 and host interaction. | Front Immunol | 2022 | 36713387 | PubTator, text mining | PubMed |
| The role of oxidative stress in the pathogenesis of infections with coronaviruses. | Front Microbiol | 2022 | 36713204 | PubTator, text mining | PubMed |
| Continuous genomic diversification of long polynucleotide fragments drives the emergence of new SARS-CoV-2 variants of concern. | PNAS Nexus | 2022 | 36712796 | PubTator, text mining | PubMed |
| Emergence of human-porcine reassortment G9P[19] porcine rotavirus A strain in Guangdong Province, China. | Front Vet Sci | 2022 | 36699335 | PubTator, text mining | PubMed |
| Genomic Tracking of SARS-CoV-2 Variants in Myanmar. | Vaccines (Basel) | 2022 | 36679850 | PubTator, text mining | PubMed |
| Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects. | Pathogens | 2022 | 36678387 | PubTator, text mining | PubMed |
| Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro) Identified from the Library of FDA-Approved Drugs Using Molecular Docking Studies. | Biomedicines | 2022 | 36672593 | PubTator, text mining | PubMed |
| Interplay between swine enteric coronaviruses and host innate immune. | Front Vet Sci | 2022 | 36619958 | PubTator, text mining | PubMed |
| Modelling the Transitioning of SARS-CoV-2 nsp3 and nsp4 Lumenal Regions towards a More Stable State on Complex Formation. | Int J Mol Sci | 2022 | 36614163 | PubTator, text mining | PubMed |
| Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor. | Cells | 2022 | 36611877 | PubTator, text mining | PubMed |
| Recent changes in the mutational dynamics of the SARS-CoV-2 main protease substantiate the danger of emerging resistance to antiviral drugs. | Front Med (Lausanne) | 2022 | 36590977 | PubTator, text mining | PubMed |
| The SARS-CoV-2 Delta (B.1.617.2) variant with spike N501Y mutation in the shadow of Omicron emergence. | Heliyon | 2022 | 36590492 | PubTator, text mining | PubMed |
| Targeted therapy of RET fusion-positive non-small cell lung cancer. | Front Oncol | 2022 | 36582799 | PubTator, text mining | PubMed |
| Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells. | Front Pharmacol | 2022 | 36582523 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=33